AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8800
-0.0500 (-5.38%)
At close: Oct 29, 2025, 4:00 PM EDT
0.8800
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:00 PM EDT
AEON Biopharma Employees
AEON Biopharma had 5 employees as of December 31, 2024. The number of employees decreased by 5 or -50.00% compared to the previous year.
Employees
5
Change (1Y)
-5
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$327,200
Market Cap
10.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Dec 31, 2022 | 8 | -12 | -60.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AEON News
- 4 weeks ago - AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - GlobeNewsWire
- 2 months ago - AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 5 months ago - AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - GlobeNewsWire
- 6 months ago - AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - GlobeNewsWire
- 6 months ago - AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - GlobeNewsWire
- 7 months ago - AEON Biopharma Announces CEO Transition - GlobeNewsWire